Unilever exploring $4 billion bid for Thorne supplements
Key takeaways
- L Catterton, Thorne's private equity owner, has initiated a sale process that has attracted multiple potential buyers, of which Unilever is one.
- The asking price, $4 billion, would dwarf the $680 million L Catterton paid to take Thorne private in 2023 — a deal that would yield enormous gains for the LVMH-backed firm.
- Consumer healthcare group Haleon has also submitted a bid for Thorne, according to Reuters.
Unilever exploring $4 billion bid for Thorne supplements Unilever exploring $4 billion bid for Thorne supplements · Quartz · Nur Photo / Getty Images Colleen Cabili Fri, June 26, 2026 at 11:05 PM GMT+7 2 min read UL MC.PA HLN According to the Financial Times, the consumer goods giant has set its sights on acquiring Thorne, a U.S. dietary supplements brand. L Catterton, Thorne's private equity owner, has initiated a sale process that has attracted multiple potential buyers, of which Unilever is one.
The asking price, $4 billion, would dwarf the $680 million L Catterton paid to take Thorne private in 2023 — a deal that would yield enormous gains for the LVMH-backed firm. Thorne, which has been in operation since 1984, is on track for $650 million in annual revenues and offers products such as magnesium and omega-3 supplements. Since coming under L Catterton's control, Thorne has posted compounded annual revenue growth exceeding 30 percent.
Consumer healthcare group Haleon has also submitted a bid for Thorne, according to Reuters. A Haleon spokesperson said the company does not comment on rumor or speculation. Unilever and L Catterton both declined to comment.